Antons syndrome in a patient with type-2 heparin-induced thrombocytopaenia (HIT).
Krovvidi
H
H
Bhattacharjee
A
A
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D019575:Blindness, Cortical / Q000150:complications / Q000175:diagnosis*; D020520:Brain Infarction / Q000150:complications / Q000175:diagnosis; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006629:Hirudins / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008638:Mesenteric Arteries / Q000000981:diagnostic imaging / Q000503:physiopathology; D009778:Occipital Lobe / Q000098:blood supply / Q000503:physiopathology; D010446:Peptide Fragments / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications*; D013927:Thrombosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin